Clinical Trials Directory

Trials / Completed

CompletedNCT03529201

QLB After Nephrectomy

Effectiveness of Quadratus Lumborum Block After Nephrectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Medical University of Lublin · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Oxycodone consumption and postoperative pain intensity in patients undergoing nephrectomy procedures. Of all study participants, 50% will obtain quadratus lumborum block (QLB).

Detailed description

Patients undergoing nephrectomy procedures will be allocated to one of the study arms. At the end of an operation, still under general anesthesia, 50% patients will obtain QLB with ropivacaine. Ultrasound-guided QLB will be performed on the side of surgery with 0.375% ropivacaine solution (0.2 mL per kg). Every patient will get patient-controlled analgesia pump with oxycodone in the postoperative period. Postoperative pain will be measured with VAS (visual-analogue scale) 2, 4, 8, 12 and 24 hours after the end of the operation. 24 -hours period. At the 1, 3, 6 months patients will be interviewed by phone to assess neuropathic pain. Neuropathic Pain Symptom Inventory (NPSI) will be used.

Conditions

Interventions

TypeNameDescription
PROCEDUREQLBOn the side of the surgery, QLB with 0.375% ropivacaine (0.2 mL/kg)
DEVICEPCAPatient-controlled analgesia
PROCEDUREGAGeneral anesthesia
DRUGOxycodoneadministered by PCA
DRUGSevofluraneInhalational anesthetic during GA
DRUGFentanylpainkiller during GA
DRUGRocuroniummuscle relaxant during GA

Timeline

Start date
2018-05-07
Primary completion
2019-02-28
Completion
2019-08-25
First posted
2018-05-18
Last updated
2023-11-24

Locations

2 sites across 1 country: Poland

Source: ClinicalTrials.gov record NCT03529201. Inclusion in this directory is not an endorsement.